Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas.
about
Mutational status of naevus-associated melanomas.A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma.Melanocytic nevi and melanoma: unraveling a complex relationship.Clinical and therapeutic implications of BRAF mutation heterogeneity in metastatic melanoma.BRAF(V600E) and NRAS(Q61L/Q61R) mutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting.
P2860
Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Concordant BRAFV600E mutation ...... testing of primary melanomas.
@en
Concordant BRAFV600E mutation ...... testing of primary melanomas.
@nl
type
label
Concordant BRAFV600E mutation ...... testing of primary melanomas.
@en
Concordant BRAFV600E mutation ...... testing of primary melanomas.
@nl
prefLabel
Concordant BRAFV600E mutation ...... testing of primary melanomas.
@en
Concordant BRAFV600E mutation ...... testing of primary melanomas.
@nl
P2093
P50
P1433
P1476
Concordant BRAFV600E mutation ...... n testing of primary melanomas
@en
P2093
James S Wilmott
John F Thompson
Oana Crainic
Sandra A O'Toole
P304
P356
10.1097/PAT.0000000000000077
P577
2014-04-01T00:00:00Z